| |
| |
|
| Insider
Information: |
Nelson Sonja |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
116,119 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$156,302 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,119 |
|
|
| Total
Value |
$156,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ImmunityBio, Inc |
IBRX |
Chief Financial Officer |
2021-01-12 |
15,410 |
2018-03-23 |
0 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
Director |
2022-01-05 |
100,709 |
2021-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MOTS |
Motus Gi Holdings Inc |
Director |
– • – |
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
82,500 |
100,709 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Director |
– • – |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
18,209 |
18,209 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
AS |
$15.00 |
$245,460 |
D/D |
(16,364) |
15,410 |
0 |
% |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
OE |
$3.07 |
$34,887 |
D/D |
11,364 |
31,774 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
AS |
$13.62 |
$534,938 |
D/D |
(39,271) |
20,410 |
0 |
% |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
OE |
$3.07 |
$69,778 |
D/D |
22,729 |
59,681 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2020-08-02 |
4 |
D |
$11.18 |
$38,660 |
D/D |
(3,458) |
36,952 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2020-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
40,410 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2020-03-23 |
4 |
D |
$2.82 |
$17,292 |
D/D |
(6,132) |
30,410 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2020-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
36,542 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2019-08-02 |
4 |
D |
$1.27 |
$4,392 |
D/D |
(3,458) |
21,542 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Financial Officer |
• – – |
2019-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chief Accounting Officer |
• – – |
2018-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
